Deals
GE Puts Debt Cuts in Forefront With $21 Billion Asset Sale
- Company is selling part of life sciences division to Danaher
- Bonds, shares rise as cost to protect against default drops
This article is for subscribers only.
General Electric Co. is taking a big step toward its goal of deleveraging its $121 billion debt load by selling part of its fast-growing life sciences division.
The industrial giant agreed to sell its biopharma business to Danaher Corp. for total consideration of $21.4 billion to help pay down debt, according to a statement Monday. The transaction is expected to close in the fourth quarter of this year.